The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Branded Generics-Global Market Insights and Sales Trends 2025
Synopsis
This report mainly focuses on branded generics market. Branded generics are generic drugs that have been given a proprietary market name. They may be marketed similarly to how branded drugs are. Branded generic drugs attach proprietary names to generic drug molecules.
The global Branded Generics market size is expected to reach US$ 523.1 million by 2029, growing at a CAGR of 8.2% from 2023 to 2029. The market is mainly driven by the significant applications of Branded Generics in various end use industries. The expanding demands from the Oncology, Cardiovascular Diseases, Diabetes and Neurology, are propelling Branded Generics market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Parenteral segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Branded Generics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Branded Generics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Branded Generics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Branded Generics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Branded Generics covered in this report include Mylan NV, Novartis AG, Eva Pharmaceutical Industries, Pfizer, Sun Pharmaceutical Industries, Aspen Pharmacare Holding, Abbott Laboratories and Bausch Health, etc.
The global Branded Generics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Mylan NV
Novartis AG
Eva Pharmaceutical Industries
Pfizer
Sun Pharmaceutical Industries
Aspen Pharmacare Holding
Abbott Laboratories
Bausch Health
Global Branded Generics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Branded Generics market, Segment by Type:
Oral
Parenteral
Topical
Other
Global Branded Generics market, by Application
Oncology
Cardiovascular Diseases
Diabetes
Neurology
Gastrointestinal Diseases
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Branded Generics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Branded Generics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
This report mainly focuses on branded generics market. Branded generics are generic drugs that have been given a proprietary market name. They may be marketed similarly to how branded drugs are. Branded generic drugs attach proprietary names to generic drug molecules.
The global Branded Generics market size is expected to reach US$ 523.1 million by 2029, growing at a CAGR of 8.2% from 2023 to 2029. The market is mainly driven by the significant applications of Branded Generics in various end use industries. The expanding demands from the Oncology, Cardiovascular Diseases, Diabetes and Neurology, are propelling Branded Generics market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Parenteral segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Branded Generics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Branded Generics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Branded Generics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Branded Generics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Branded Generics covered in this report include Mylan NV, Novartis AG, Eva Pharmaceutical Industries, Pfizer, Sun Pharmaceutical Industries, Aspen Pharmacare Holding, Abbott Laboratories and Bausch Health, etc.
The global Branded Generics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Mylan NV
Novartis AG
Eva Pharmaceutical Industries
Pfizer
Sun Pharmaceutical Industries
Aspen Pharmacare Holding
Abbott Laboratories
Bausch Health
Global Branded Generics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Branded Generics market, Segment by Type:
Oral
Parenteral
Topical
Other
Global Branded Generics market, by Application
Oncology
Cardiovascular Diseases
Diabetes
Neurology
Gastrointestinal Diseases
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Branded Generics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Branded Generics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Branded Generics Market Overview
1.1 Branded Generics Product Overview
1.2 Branded Generics Market Segment by Type
1.2.1 Oral
1.2.2 Parenteral
1.2.3 Topical
1.2.4 Other
1.3 Global Branded Generics Market Size by Type
1.3.1 Global Branded Generics Market Size Overview by Type (2018-2029)
1.3.2 Global Branded Generics Historic Market Size Review by Type (2018-2023)
1.3.3 Global Branded Generics Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Branded Generics Sales Breakdown by Type (2018-2023)
1.4.2 Europe Branded Generics Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Branded Generics Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Branded Generics Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Branded Generics Sales Breakdown by Type (2018-2023)
2 Global Branded Generics Market Competition by Company
2.1 Global Top Players by Branded Generics Sales (2018-2023)
2.2 Global Top Players by Branded Generics Revenue (2018-2023)
2.3 Global Top Players by Branded Generics Price (2018-2023)
2.4 Global Top Manufacturers Branded Generics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Branded Generics Market Competitive Situation and Trends
2.5.1 Branded Generics Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Branded Generics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Branded Generics as of 2022)
2.7 Date of Key Manufacturers Enter into Branded Generics Market
2.8 Key Manufacturers Branded Generics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Branded Generics Status and Outlook by Region
3.1 Global Branded Generics Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Branded Generics Historic Market Size by Region
3.2.1 Global Branded Generics Sales in Volume by Region (2018-2023)
3.2.2 Global Branded Generics Sales in Value by Region (2018-2023)
3.2.3 Global Branded Generics Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Branded Generics Forecasted Market Size by Region
3.3.1 Global Branded Generics Sales in Volume by Region (2024-2029)
3.3.2 Global Branded Generics Sales in Value by Region (2024-2029)
3.3.3 Global Branded Generics Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Branded Generics by Application
4.1 Branded Generics Market Segment by Application
4.1.1 Oncology
4.1.2 Cardiovascular Diseases
4.1.3 Diabetes
4.1.4 Neurology
4.1.5 Gastrointestinal Diseases
4.1.6 Others
4.2 Global Branded Generics Market Size by Application
4.2.1 Global Branded Generics Market Size Overview by Application (2018-2029)
4.2.2 Global Branded Generics Historic Market Size Review by Application (2018-2023)
4.2.3 Global Branded Generics Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Branded Generics Sales Breakdown by Application (2018-2023)
4.3.2 Europe Branded Generics Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Branded Generics Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Branded Generics Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Branded Generics Sales Breakdown by Application (2018-2023)
5 North America Branded Generics by Country
5.1 North America Branded Generics Historic Market Size by Country
5.1.1 North America Branded Generics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Branded Generics Sales in Volume by Country (2018-2023)
5.1.3 North America Branded Generics Sales in Value by Country (2018-2023)
5.2 North America Branded Generics Forecasted Market Size by Country
5.2.1 North America Branded Generics Sales in Volume by Country (2024-2029)
5.2.2 North America Branded Generics Sales in Value by Country (2024-2029)
6 Europe Branded Generics by Country
6.1 Europe Branded Generics Historic Market Size by Country
6.1.1 Europe Branded Generics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Branded Generics Sales in Volume by Country (2018-2023)
6.1.3 Europe Branded Generics Sales in Value by Country (2018-2023)
6.2 Europe Branded Generics Forecasted Market Size by Country
6.2.1 Europe Branded Generics Sales in Volume by Country (2024-2029)
6.2.2 Europe Branded Generics Sales in Value by Country (2024-2029)
7 Asia-Pacific Branded Generics by Region
7.1 Asia-Pacific Branded Generics Historic Market Size by Region
7.1.1 Asia-Pacific Branded Generics Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Branded Generics Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Branded Generics Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Branded Generics Forecasted Market Size by Region
7.2.1 Asia-Pacific Branded Generics Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Branded Generics Sales in Value by Region (2024-2029)
8 Latin America Branded Generics by Country
8.1 Latin America Branded Generics Historic Market Size by Country
8.1.1 Latin America Branded Generics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Branded Generics Sales in Volume by Country (2018-2023)
8.1.3 Latin America Branded Generics Sales in Value by Country (2018-2023)
8.2 Latin America Branded Generics Forecasted Market Size by Country
8.2.1 Latin America Branded Generics Sales in Volume by Country (2024-2029)
8.2.2 Latin America Branded Generics Sales in Value by Country (2024-2029)
9 Middle East and Africa Branded Generics by Country
9.1 Middle East and Africa Branded Generics Historic Market Size by Country
9.1.1 Middle East and Africa Branded Generics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Branded Generics Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Branded Generics Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Branded Generics Forecasted Market Size by Country
9.2.1 Middle East and Africa Branded Generics Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Branded Generics Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Mylan NV
10.1.1 Mylan NV Company Information
10.1.2 Mylan NV Introduction and Business Overview
10.1.3 Mylan NV Branded Generics Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Mylan NV Branded Generics Products Offered
10.1.5 Mylan NV Recent Development
10.2 Novartis AG
10.2.1 Novartis AG Company Information
10.2.2 Novartis AG Introduction and Business Overview
10.2.3 Novartis AG Branded Generics Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Novartis AG Branded Generics Products Offered
10.2.5 Novartis AG Recent Development
10.3 Eva Pharmaceutical Industries
10.3.1 Eva Pharmaceutical Industries Company Information
10.3.2 Eva Pharmaceutical Industries Introduction and Business Overview
10.3.3 Eva Pharmaceutical Industries Branded Generics Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Eva Pharmaceutical Industries Branded Generics Products Offered
10.3.5 Eva Pharmaceutical Industries Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Branded Generics Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Pfizer Branded Generics Products Offered
10.4.5 Pfizer Recent Development
10.5 Sun Pharmaceutical Industries
10.5.1 Sun Pharmaceutical Industries Company Information
10.5.2 Sun Pharmaceutical Industries Introduction and Business Overview
10.5.3 Sun Pharmaceutical Industries Branded Generics Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Sun Pharmaceutical Industries Branded Generics Products Offered
10.5.5 Sun Pharmaceutical Industries Recent Development
10.6 Aspen Pharmacare Holding
10.6.1 Aspen Pharmacare Holding Company Information
10.6.2 Aspen Pharmacare Holding Introduction and Business Overview
10.6.3 Aspen Pharmacare Holding Branded Generics Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Aspen Pharmacare Holding Branded Generics Products Offered
10.6.5 Aspen Pharmacare Holding Recent Development
10.7 Abbott Laboratories
10.7.1 Abbott Laboratories Company Information
10.7.2 Abbott Laboratories Introduction and Business Overview
10.7.3 Abbott Laboratories Branded Generics Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Abbott Laboratories Branded Generics Products Offered
10.7.5 Abbott Laboratories Recent Development
10.8 Bausch Health
10.8.1 Bausch Health Company Information
10.8.2 Bausch Health Introduction and Business Overview
10.8.3 Bausch Health Branded Generics Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Bausch Health Branded Generics Products Offered
10.8.5 Bausch Health Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Branded Generics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Branded Generics Industrial Chain Analysis
11.4 Branded Generics Market Dynamics
11.4.1 Branded Generics Industry Trends
11.4.2 Branded Generics Market Drivers
11.4.3 Branded Generics Market Challenges
11.4.4 Branded Generics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Branded Generics Distributors
12.3 Branded Generics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
